Autolus announces FELIX trial of obe-cel meets its primary endpoint09 December 2022Syncona Ltd, a leading healthcare company focused on creating, building and scaling global leaders in life science, notes that its portfolio company, Autolus Therapeutics Plc (Nasdaq: AUTL) (“Autolus”), has announced that.